1.0CRS4https://www.crs4.it/en/Gavino Paddeuhttps://www.crs4.it/en/author/gavino/rich600338<blockquote class="wp-embedded-content" data-secret="1EC4sMePrw"><a href="https://www.crs4.it/en/projects/dp-airc/">DP AIRC</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://www.crs4.it/en/projects/dp-airc/embed/#?secret=1EC4sMePrw" width="600" height="338" title="“DP AIRC” — CRS4" data-secret="1EC4sMePrw" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://www.crs4.it/wp-includes/js/wp-embed.min.js </script> The Turin Prostate Cancer Prognostication (TPCP) is an observational cohort study sponsored by the Department of Medical Sciences of the University of Turin, funded by the AIRC Foundation for Cancer Research, and started during 2021 at the AOU Città della Salute e della Scienza di Torino.The TPCP study aims to develop, through a new integrated […]